Table of Contents

1 Study Coverage

• 1.1 Liraglutide Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Liraglutide Market Size Growth Rate by Product
  • 1.4.2 Pills
  • 1.4.3 Liquid
• 1.5 Market by End User
  • 1.5.1 Global Liraglutide Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Drug Store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Liraglutide Market Size
  • 2.1.1 Global Liraglutide Revenue 2014-2025
  • 2.1.2 Global Liraglutide Sales 2014-2025
• 2.2 Liraglutide Growth Rate by Regions
  • 2.2.1 Global Liraglutide Sales by Regions
  • 2.2.2 Global Liraglutide Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Liraglutide Sales by Manufacturers
  • 3.1.1 Liraglutide Sales by Manufacturers
  • 3.1.2 Liraglutide Sales Market Share by Manufacturers
  • 3.1.3 Global Liraglutide Market Concentration Ratio (CR5 and HHI)
• 3.2 Liraglutide Revenue by Manufacturers
  • 3.2.1 Liraglutide Revenue by Manufacturers (2014-2019)
  • 3.2.2 Liraglutide Revenue Share by Manufacturers (2014-2019)
• 3.3 Liraglutide Price by Manufacturers
• 3.4 Liraglutide Manufacturing Base Distribution, Product Types
  • 3.4.1 Liraglutide Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Liraglutide Product Type
  • 3.4.3 Date of International Manufacturers Enter into Liraglutide Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Liraglutide Sales by Product
• 4.2 Global Liraglutide Revenue by Product
• 4.3 Liraglutide Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Liraglutide Breakdown Data by End User

6 North America

• 6.1 North America Liraglutide by Countries
  • 6.1.1 North America Liraglutide Sales by Countries
  • 6.1.2 North America Liraglutide Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Liraglutide by Product
• 6.3 North America Liraglutide by End User

7 Europe

• 7.1 Europe Liraglutide by Countries
  • 7.1.1 Europe Liraglutide Sales by Countries
  • 7.1.2 Europe Liraglutide Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Liraglutide by Product
• 7.3 Europe Liraglutide by End User

8 Asia Pacific

• 8.1 Asia Pacific Liraglutide by Countries
  • 8.1.1 Asia Pacific Liraglutide Sales by Countries
  • 8.1.2 Asia Pacific Liraglutide Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Liraglutide by Product
• 8.3 Asia Pacific Liraglutide by End User

9 Central & South America

• 9.1 Central & South America Liraglutide by Countries
  • 9.1.1 Central & South America Liraglutide Sales by Countries
  • 9.1.2 Central & South America Liraglutide Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Liraglutide by Product
• 9.3 Central & South America Liraglutide by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Liraglutide by Countries
  • 10.1.1 Middle East and Africa Liraglutide Sales by Countries
  • 10.1.2 Middle East and Africa Liraglutide Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Liraglutide by Product
• 10.3 Middle East and Africa Liraglutide by End User

11 Company Profiles

• 11.1 HEC Pharm
  • 11.1.1 HEC Pharm Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 HEC Pharm Liraglutide Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 HEC Pharm Liraglutide Products Offered
  • 11.1.5 HEC Pharm Recent Development
• 11.2 Teva
  • 11.2.1 Teva Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Teva Liraglutide Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Teva Liraglutide Products Offered
  • 11.2.5 Teva Recent Development
• 11.3 Bachem
  • 11.3.1 Bachem Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Bachem Liraglutide Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Bachem Liraglutide Products Offered
  • 11.3.5 Bachem Recent Development
• 11.4 Bharat Pharmaceuticals
  • 11.4.1 Bharat Pharmaceuticals Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Bharat Pharmaceuticals Liraglutide Products Offered
  • 11.4.5 Bharat Pharmaceuticals Recent Development
• 11.5 Kingpep Biotechnology
  • 11.5.1 Kingpep Biotechnology Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Kingpep Biotechnology Liraglutide Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Kingpep Biotechnology Liraglutide Products Offered
  • 11.5.5 Kingpep Biotechnology Recent Development
• 11.6 Shenzhen JYMed Technology
  • 11.6.1 Shenzhen JYMed Technology Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Shenzhen JYMed Technology Liraglutide Products Offered
  • 11.6.5 Shenzhen JYMed Technology Recent Development
• 11.7 Wuxi Asiapeptide
  • 11.7.1 Wuxi Asiapeptide Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Wuxi Asiapeptide Liraglutide Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Wuxi Asiapeptide Liraglutide Products Offered
  • 11.7.5 Wuxi Asiapeptide Recent Development
• 11.8 AmbioPharm
  • 11.8.1 AmbioPharm Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 AmbioPharm Liraglutide Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 AmbioPharm Liraglutide Products Offered
  • 11.8.5 AmbioPharm Recent Development

12 Future Forecast

• 12.1 Liraglutide Market Forecast by Regions
  • 12.1.1 Global Liraglutide Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Liraglutide Revenue Forecast by Regions 2019-2025
• 12.2 Liraglutide Market Forecast by Product
  • 12.2.1 Global Liraglutide Sales Forecast by Product 2019-2025
  • 12.2.2 Global Liraglutide Revenue Forecast by Product 2019-2025
• 12.3 Liraglutide Market Forecast by End User
• 12.4 North America Liraglutide Forecast
• 12.5 Europe Liraglutide Forecast
• 12.6 Asia Pacific Liraglutide Forecast
• 12.7 Central & South America Liraglutide Forecast
• 12.8 Middle East and Africa Liraglutide Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Liraglutide Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Liraglutide market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Liraglutide market based on company, product type, end user and key regions.

This report studies the global market size of Liraglutide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Liraglutide in these regions.
This research report categorizes the global Liraglutide market by top players/brands, region, type and end user. This report also studies the global Liraglutide market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
HEC Pharm
Teva
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm

Market size by Product
Pills
Liquid
Market size by End User
Hospital
Drug Store

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Liraglutide market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Liraglutide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Liraglutide companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Liraglutide submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Liraglutide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Liraglutide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.